LRG1 | Leucine-rich alpha-2-glycoprotein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TTC36 | Tetratricopeptide repeat domain 36 | Predicted intracellular proteins
| | | | | Tissue enriched |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Group enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
GATM | Glycine amidinotransferase (L-arginine:glycine amidinotransferase) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
GCKR | Glucokinase (hexokinase 4) regulator | Predicted intracellular proteins
| | | | | Tissue enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
HSD11B1 | Hydroxysteroid (11-beta) dehydrogenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PZP | Pregnancy-zone protein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
GAS2 | Growth arrest-specific 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HNF1A | HNF1 homeobox A | Cancer-related genes Predicted intracellular proteins
| | | | | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |